EFRA | IGF | EFRA / IGF | |
Gain YTD | 10.851 | 14.872 | 73% |
Net Assets | 5.44M | 7.51B | 0% |
Total Expense Ratio | 0.47 | 0.42 | 112% |
Turnover | 15.00 | 13.00 | 115% |
Yield | 3.67 | 3.10 | 118% |
Fund Existence | 3 years | 18 years | - |
EFRA | IGF | |
---|---|---|
RSI ODDS (%) | 5 days ago80% | 5 days ago76% |
Stochastic ODDS (%) | 5 days ago59% | 5 days ago80% |
Momentum ODDS (%) | 5 days ago80% | 5 days ago83% |
MACD ODDS (%) | 5 days ago70% | 5 days ago86% |
TrendWeek ODDS (%) | 5 days ago74% | 5 days ago81% |
TrendMonth ODDS (%) | 5 days ago70% | 5 days ago79% |
Advances ODDS (%) | N/A | 8 days ago83% |
Declines ODDS (%) | N/A | 21 days ago81% |
BollingerBands ODDS (%) | 5 days ago76% | 5 days ago76% |
Aroon ODDS (%) | 5 days ago72% | 5 days ago80% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
QIS | 22.62 | 0.41 | +1.85% |
Simplify Multi-QIS Alternative ETF | |||
VFMF | 137.29 | 1.09 | +0.80% |
Vanguard US Multifactor ETF | |||
ESML | 42.52 | 0.32 | +0.76% |
iShares ESG Aware MSCI USA Small-Cap ETF | |||
FTXH | 26.31 | N/A | +0.01% |
First Trust Nasdaq Pharmaceuticals ETF | |||
FMCE | 26.35 | N/A | N/A |
FM Compounders Equity ETF |
A.I.dvisor indicates that over the last year, EFRA has been closely correlated with PNR. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if EFRA jumps, then PNR could also see price increases.
Ticker / NAME | Correlation To EFRA | 1D Price Change % | ||
---|---|---|---|---|
EFRA | 100% | N/A | ||
PNR - EFRA | 73% Closely correlated | +0.95% | ||
WTS - EFRA | 72% Closely correlated | +1.03% | ||
FELE - EFRA | 71% Closely correlated | +0.04% | ||
XYL - EFRA | 70% Closely correlated | N/A | ||
WTRG - EFRA | 69% Closely correlated | -0.89% | ||
More |
A.I.dvisor indicates that over the last year, IGF has been closely correlated with SRE. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if IGF jumps, then SRE could also see price increases.